Abeona Therapeutics (ABEO) Total Liabilities (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Total Liabilities of $53.6 million for Q1 2026, down 7.61% year-over-year from $58.0 million in Q1 2025, and down 11.27% quarter-over-quarter from $60.4 million in Q4 2025.
Abeona Therapeutics (ABEO) Total Liabilities (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Total Liabilities history runs 17 years deep, the most recent figure standing at $53.6 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 7.61% year-over-year to $53.6 million; the TTM figure through Mar 2026 stood at $53.6 million (down 7.61% YoY), while the FY2025 annual figure was $60.4 million, down 7.0% from the prior year.
- Total Liabilities for Q1 2026 stood at $53.6 million, down from $60.4 million in the prior quarter.
- The five-year high for Total Liabilities was $83.7 million in Q1 2024, with the low at $23.3 million in Q3 2022.
- The 5-year median for Total Liabilities is $53.6 million (2026), against an average of $51.8 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities slumped 49.56% in 2022, then soared 141.9% in 2024.
- Abeona Therapeutics' Total Liabilities stood at $37.5 million in 2022, then surged by 31.3% to $49.2 million in 2023, then soared by 31.97% to $64.9 million in 2024, then fell by 7.0% to $60.4 million in 2025, then fell by 11.27% to $53.6 million in 2026.
- Business Quant data shows ABEO's Total Liabilities at $53.6 million in Q1 2026, $60.4 million in Q4 2025, and $59.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 51.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.45 Mn |
| Mar 31, 2026 | 53.56 Mn |
| Dec 31, 2025 | 60.35 Mn |
| Sep 30, 2025 | 59.86 Mn |
| Jun 30, 2025 | 82.66 Mn |
| Mar 31, 2025 | 57.97 Mn |
| Dec 31, 2024 | 64.90 Mn |
| Sep 30, 2024 | 74.82 Mn |
| Jun 30, 2024 | 60.76 Mn |
| Mar 31, 2024 | 83.71 Mn |
| Dec 31, 2023 | 49.18 Mn |
| Sep 30, 2023 | 44.05 Mn |
| Jun 30, 2023 | 44.21 Mn |
| Mar 31, 2023 | 34.61 Mn |
| Dec 31, 2022 | 37.45 Mn |
| Sep 30, 2022 | 23.35 Mn |
| Jun 30, 2022 | 24.63 Mn |
| Mar 31, 2022 | 23.73 Mn |
| Dec 31, 2021 | 37.22 Mn |
| Sep 30, 2021 | 39.28 Mn |